298 related articles for article (PubMed ID: 1153500)
21. Pharmacokinetic profile of antipyrine in young rhesus monkeys (Macaca mulatta) with protein energy malnutrition.
Sharma B; Mehta S; Nain CK; Mathur VS
Drug Nutr Interact; 1985; 3(2):93-8. PubMed ID: 3921335
[TBL] [Abstract][Full Text] [Related]
22. Spironolactone and enzyme induction in patients with alcoholic cirrhosis.
Miguet JP; Vuitton D; Thebault-Lucas A; Joanne C; Dhumeaux D
Gastroenterology; 1980 May; 78(5 Pt 1):996-1000. PubMed ID: 7380205
[TBL] [Abstract][Full Text] [Related]
23. Microsomal enzymes in patients with gastric carcinoma as determined by plasma half-life of antipyrine.
Higuchi T; Nakamura T; Uchino H
Gan; 1978 Dec; 69(6):753-6. PubMed ID: 750270
[TBL] [Abstract][Full Text] [Related]
24. Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine.
Sultatos LG; Dvorchik BH; Vesell ES; Shand DG; Branch RA
Clin Pharmacokinet; 1980; 5(3):263-73. PubMed ID: 7389235
[No Abstract] [Full Text] [Related]
25. Elimination of antipyrine from saliva as a measure of metabolism in man.
Welch RM; DeAngelis RL; Wingfield M; Farmer TW
Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
[TBL] [Abstract][Full Text] [Related]
26. Unaltered metabolism of antipyrine and tolbutamide in fasting man.
Reidenberg MM; Vesell ES
Clin Pharmacol Ther; 1975 Jun; 17(6):650-6. PubMed ID: 1139856
[TBL] [Abstract][Full Text] [Related]
27. Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.
Breckenridge A; Burke CW; Davies DS; Orme ML
Br J Pharmacol; 1973 Feb; 47(2):434-6. PubMed ID: 4722054
[TBL] [Abstract][Full Text] [Related]
28. Effect of chloroquine and primaquine on antipyrine metabolism.
Back DJ; Purba HS; Park BK; Ward SA; Orme ML
Br J Clin Pharmacol; 1983 Nov; 16(5):497-502. PubMed ID: 6639836
[TBL] [Abstract][Full Text] [Related]
29. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
[TBL] [Abstract][Full Text] [Related]
30. Effects of drug pretreatment on antipyrine elimination in the rabbit.
Chambers DM; Jefferson GC
Pharmacology; 1982; 24(2):88-95. PubMed ID: 7079291
[TBL] [Abstract][Full Text] [Related]
31. Induction of microsomal enzyme activity by flupenthixol in chronic schizophrenics.
Salem SA; King DJ; McDevitt DG
Psychopharmacology (Berl); 1982; 78(2):147-9. PubMed ID: 6817372
[TBL] [Abstract][Full Text] [Related]
32. Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanol.
Benowitz NL; Jones RT
Clin Pharmacol Ther; 1977 Sep; 22(3):259-68. PubMed ID: 891094
[TBL] [Abstract][Full Text] [Related]
33. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
34. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
[TBL] [Abstract][Full Text] [Related]
35. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
Rivière JH; Back DJ; Breckenridge AM; Howells RE
Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
[TBL] [Abstract][Full Text] [Related]
36. Impairment of human antipyrine metabolism by piroxicam.
Battellino LJ; Dorronsoro de Cattoni ST; Ragagnin C
Can J Physiol Pharmacol; 1990 Jun; 68(6):711-7. PubMed ID: 2372742
[TBL] [Abstract][Full Text] [Related]
37. Influence of short-term water deprivation on antipyrine disposition.
Prasad P; Jung D; Niazi S
J Pharm Sci; 1985 Mar; 74(3):338-9. PubMed ID: 4009446
[TBL] [Abstract][Full Text] [Related]
38. Impairment of antipyrine clearance in humans by propranolol.
Greenblatt DJ; Franke K; Huffman DH
Circulation; 1978 Jun; 57(6):1161-64. PubMed ID: 639239
[TBL] [Abstract][Full Text] [Related]
39. The effect of anti-cancer drugs on pharmacokinetics of antipyrine in vitamin A deficiency.
Khanduja KL; Dogra SC; Kaushal S; Sharma RR
Biochem Pharmacol; 1984 Feb; 33(3):449-52. PubMed ID: 6704163
[TBL] [Abstract][Full Text] [Related]
40. The effect of oral verapamil therapy on antipyrine clearance.
Rumiantsev DO; Piotrovskii VK; Riabokon OS; Slastnikova ID; Kokurina EV; Metelitsa VI
Br J Clin Pharmacol; 1986 Nov; 22(5):606-9. PubMed ID: 3790408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
